Dramatic improvement after tocilizumab of severe COVID ‐19 in a child with sickle cell disease and acute chest syndrome

Vaso‐occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease ( COVID ‐19)

(2020) Erfan Nur et al.   AMERICAN JOURNAL OF HEMATOLOGY

Rapid and severe Covid‐19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab

(2020) Gonzalo De Luna et al.   AMERICAN JOURNAL OF HEMATOLOGY

COVID ‐19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient

(2020) Frans Beerkens et al.   AMERICAN JOURNAL OF HEMATOLOGY

Why tocilizumab could be an effective treatment for severe COVID-19?

(2020) Binqing Fu et al.   Journal of Translational Medicine

Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab

(2020) M. Cellina et al.   Diagnostic and Interventional Imaging

Inflammation in sickle cell disease

(2018) Nicola Conran et al.   CLINICAL HEMORHEOLOGY AND MICROCIRCULATION